Skip to main content

INSIGHTS AND PERSPECTIVES

  • Mintel: Easter-themed chocolate market 'recession resistant'

    CHICAGO — Global Easter-themed chocolate product launches have increased 45% over the past year, according to new Mintel research.

  • Social media could soften impact of negative word of mouth

    ANN ARBOR, Mich. — Social media may have the ability to ease negative word-of-mouth impact, according to a leader in customer experience management solutions.

  • Walgreens immunization studies: Pharmacy instrumental in helping states combat disease

    DEERFIELD, Ill. — Walgreens on Tuesday released case studies presented last week before the Centers for Disease Control and Prevention's 2012 National Immunization Conference on how retail pharmacy can expand access to immunizations and help support disease-prevention initiatives.

    The studies demonstrated the impact of three Walgreens initiatives aimed at increasing immunization rates: off-clinic hour vaccine administration, a pharmacist-led meningitis vaccination program and expansion of access to immunization services in underserved areas.

  • CDC report: Some ethnic groups need to boost vitamin D, iron supplementation

    ATLANTA — Overall, the U.S. population has good levels of vitamin A and folate in the body, but some groups still need to increase their levels of vitamin D and iron, according to the "Second National Report on Biochemical Indicators of Diet and Nutrition," released Monday by the Centers for Disease Control and Prevention.

  • Metformin may help slow progression, reduce risk of certain cancers

    NEW YORK — A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

    In three separate studies published in Cancer Prevention Research, a journal of the American Association for Cancer Research, findings showed how metformin may protect against oral cancer and liver cancer, as well as slow the growth rate of prostate cancer among men prior to prostatectomy.

  • Astellas, Vical finalize design for phase-3 cytomegalovirus vaccine trial

    SAN DIEGO — Two drug makers have finalized the design of a late-stage clinical trial for a vaccine against a common virus that can cause complications later in life.

    Vical and Astellas Pharma announced Monday that they had finalized the general design of a phase-3 trial of TransVax, a vaccine against cytomegalovirus, or CMV, for transplant recipients.

  • Express Scripts struck a match to the merger debate after suggesting approval imminent

    WHAT IT MEANS AND WHY IT'S IMPORTANT — When Express Scripts filed with the Securities & Exchange Commission that its merger with Medco could close as early as the week of April 2, that seemed to set off a firestorm of activity. Reports were published suggesting the Federal Trade Commission decision was imminent, and what's more that the agency would decide in favor of the merger. Speculative day traders Wednesday morning pushed the opening stock prices across both Express Scripts and Medco higher by 3.9% and 5%, respectively.

  • Report: Cancer death rates continue to decline

    ATLANTA — Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

X
This ad will auto-close in 10 seconds